Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eprosartan vs Eprosartan Mesylate in Essential Hypertension
NCT01631227Phase 3Completed
- Sponsor
- Abbott Laboratories
- Start
- Jun 2012
- Primary completion
- Apr 2013
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of eprosartan in essential hypertension, sponsored by Abbott Laboratories. Started Jun 2012; status: completed.
02
Drugs
eprosartan
03
Conditions
essential hypertension
Beyond the preview
Go deeper on NCT01631227.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01631227.